Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct

NCT04504851 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT04504851
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04504851 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct
Lead sponsor
National University Hospital, Singapore
Phase
Phase 2
Overall status
Unknown status
Start date
August 12, 2020
Completion date
March 31, 2021
Enrollment
154 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary tuberculosis